Full Text View
Tabular View
No Study Results Posted
Related Studies
An Efficacy and Safety Study of Ixmyelocel-T in Patients With Critical Limb Ischemia (CLI) (REVIVE)
This study has been terminated.
( Patient enrollment stopped for business reasons; no safety concerns. )
Study NCT01483898   Information provided by Aastrom Biosciences

First Received on November 30, 2011.   Last Updated on April 1, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Critical Limb Ischemia
Additional conditions recognized in this trial
Ischemia
More general conditions related to this trial
Pathologic Processes
Interventions listed in this trial
Ixmyelocel-T
Vehicle Control
Sponsors listed in this trial
Aastrom Biosciences


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services